43.58
0.61 (1.42%)
| Penutupan Terdahulu | 42.97 |
| Buka | 42.73 |
| Jumlah Dagangan | 16,531,027 |
| Purata Dagangan (3B) | 20,183,452 |
| Modal Pasaran | 64,775,360,512 |
| Harga / Pendapatan (P/E TTM) | 18.01 |
| Harga / Pendapatan (P/E Ke hadapan) | 13.12 |
| Harga / Jualan (P/S) | 3.19 |
| Harga / Buku (P/B) | 2.53 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Jul 2026 |
| Margin Keuntungan | 11.58% |
| Margin Operasi (TTM) | 20.09% |
| EPS Cair (TTM) | 1.37 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 20.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 36.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 52.16% |
| Nisbah Semasa (MRQ) | 1.45 |
| Aliran Tunai Operasi (OCF TTM) | 3.81 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.32 B |
| Pulangan Atas Aset (ROA TTM) | 5.28% |
| Pulangan Atas Ekuiti (ROE TTM) | 9.50% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Boston Scientific Corporation | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.17 |
|
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Large Core |
| % Dimiliki oleh Orang Dalam | 0.18% |
| % Dimiliki oleh Institusi | 93.22% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |